Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (ανοίγει νέο παράθυρο)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Πηγή‎: Hemoglobin 2014;38(1):44-8.

Καταχώριση‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (ανοίγει νέο παράθυρο)

Hydroxyurea in thalassemia intermedia--a promising therapy. (ανοίγει νέο παράθυρο)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Πηγή‎: Ann Hematol 2005;84(7):441-6.

Καταχώριση‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (ανοίγει νέο παράθυρο)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (ανοίγει νέο παράθυρο)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Πηγή‎: J Clin Pathol 2010;63(2):147-50.

Καταχώριση‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (ανοίγει νέο παράθυρο)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (ανοίγει νέο παράθυρο)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Πηγή‎: Eur J Haematol 2009;82(3):213-8.

Καταχώριση‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (ανοίγει νέο παράθυρο)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (ανοίγει νέο παράθυρο)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Πηγή‎: Eur J Haematol 2010;84(1):52-8.

Καταχώριση‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (ανοίγει νέο παράθυρο)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (ανοίγει νέο παράθυρο)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Πηγή‎: Blood Cells Mol Dis 2000;26(5):453-66.

Καταχώριση‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (ανοίγει νέο παράθυρο)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (ανοίγει νέο παράθυρο)

Perrine SP.

Πηγή‎: Pediatr Ann 2008;37(5):339-46.

Καταχώριση‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (ανοίγει νέο παράθυρο)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (ανοίγει νέο παράθυρο)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Πηγή‎: Ann N Y Acad Sci 2005;1054:250-6.

Καταχώριση‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (ανοίγει νέο παράθυρο)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (ανοίγει νέο παράθυρο)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Πηγή‎: Acta Haematol 2004;111(4):189-95.

Καταχώριση‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (ανοίγει νέο παράθυρο)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (ανοίγει νέο παράθυρο)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Πηγή‎: Blood Purif 2004;22(5):453-60.

Καταχώριση‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (ανοίγει νέο παράθυρο)

The role of recombinant human erythropoietin in the treatment of thalassemia. (ανοίγει νέο παράθυρο)

Rachmilewitz EA, Aker M.

Πηγή‎: Ann N Y Acad Sci 1998;850:129-38.

Καταχώριση‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (ανοίγει νέο παράθυρο)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (ανοίγει νέο παράθυρο)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Πηγή‎: Br J Haematol 2011;154(2):281-4.

Καταχώριση‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (ανοίγει νέο παράθυρο)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (ανοίγει νέο παράθυρο)

Thein SL.

Πηγή‎: Blood Rev 2012;26 Suppl 1:S35-9.

Καταχώριση‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (ανοίγει νέο παράθυρο)